Bysspectin A derivative, and preparation method and medicinal application thereof
The invention belongs to the technical field of medicines, and relates to a preparation method and medicinal application of a BysspectinA derivative with hCES2A inhibitory activity as shown in a general formula I and a composition thereof, in particular to application of the BysspectinA derivative and the composition in preparation of medicines for treating and (or) preventing diseases (diarrhea and diarrhea side effects caused by cancer treatment) related to the hCES2A inhibitory activity..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 05. Sept. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
JIAO XIAOZHEN [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-09-05, Last update posted on www.tib.eu: 2024-03-12, Last updated: 2024-03-15 |
|---|
| Patentnummer: |
CN116693479 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA000848948 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA000848948 | ||
| 003 | DE-627 | ||
| 005 | 20240315102244.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA000848948 | ||
| 035 | |a (EPA)CN116693479 | ||
| 035 | |a (EPA)87829876 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a JIAO XIAOZHEN |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bysspectin A derivative, and preparation method and medicinal application thereof |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-09-05, Last update posted on www.tib.eu: 2024-03-12, Last updated: 2024-03-15 | ||
| 520 | |a The invention belongs to the technical field of medicines, and relates to a preparation method and medicinal application of a BysspectinA derivative with hCES2A inhibitory activity as shown in a general formula I and a composition thereof, in particular to application of the BysspectinA derivative and the composition in preparation of medicines for treating and (or) preventing diseases (diarrhea and diarrhea side effects caused by cancer treatment) related to the hCES2A inhibitory activity. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a GE GUANGBO |4 aut | |
| 700 | 0 | |a WU YUANYUAN |4 aut | |
| 700 | 0 | |a XIE PING |4 aut | |
| 700 | 0 | |a LIU XIAOYU |4 aut | |
| 700 | 0 | |a SONG YUNQING |4 aut | |
| 700 | 0 | |a ZHANG YA |4 aut | |
| 700 | 0 | |a MA BO |4 aut | |
| 700 | 0 | |a LI WENXUAN |4 aut | |
| 700 | 0 | |a WANG YUAN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 05. Sept. |
| 773 | 1 | 8 | |g year:2023 |g day:05 |g month:09 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/87829876/publication/CN116693479A1?q=CN116693479 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 05 |c 09 | ||